Cita APA (7a ed.)
Lingjet Tran, K., Park, Y. I., Pandya, S., Muliyil, N. J., Jensen, B. D., Huynh, K., & Nguyen, Q. T. (2017). Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes... [including commentary by Raymond Plodkowski]. American Health & Drug Benefits, 10(4), 178-189.
Cita Chicago Style (17a ed.)
Lingjet Tran, Kelvin, Young In Park, Shalin Pandya, Navin John Muliyil, Brandon David Jensen, Kovin Huynh, y Quang T. Nguyen. "Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes... [including Commentary by Raymond Plodkowski]." American Health & Drug Benefits 10, no. 4 (2017): 178-189.
Cita MLA (9a ed.)
Lingjet Tran, Kelvin, et al. "Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes... [including Commentary by Raymond Plodkowski]." American Health & Drug Benefits, vol. 10, no. 4, 2017, pp. 178-189.
Precaución: Estas citas no son 100% exactas.